Y-mAbs Therapeutics is based in New York, NY. It has raised $120M in total funding.
Y-mAbs Therapeutics funding overview
Y-mAbs Therapeutics is based in New York, NY. Y-mAbs Therapeutics has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Investors on record include HBM Healthcare Investments (Cayman) Ltd., Scopia Capital Management LP, Sofinnova Ventures, Inc.. 3 distinct backers are named across the disclosed rounds.
Y-mAbs Therapeutics at a glance
Total raised
$120M
Headquarters
New York, NY
Notable investors
HBM Healthcare Investments (Cayman) Ltd., Scopia Capital Management LP, Sofinnova Ventures, Inc.
Frequently asked about Y-mAbs Therapeutics funding
How much has Y-mAbs Therapeutics raised?
Y-mAbs Therapeutics has raised $120M in total disclosed funding across the rounds on record.
Who has invested in Y-mAbs Therapeutics?
HBM Healthcare Investments (Cayman) Ltd., Scopia Capital Management LP, Sofinnova Ventures, Inc. are named among the investors backing Y-mAbs Therapeutics.
What was the latest Y-mAbs Therapeutics funding round?
No round stage has been disclosed for Y-mAbs Therapeutics.
Where is Y-mAbs Therapeutics based?
Y-mAbs Therapeutics is based in New York, NY.
Y-mAbs Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in New York below to benchmark round size and investor mix.
